Vontobel Holding Ltd. Cidara Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jun 03, 2024
BUY
$1.01 - $1.42 $29,637 - $41,668
29,344 Added 55.53%
82,185 $92,000
Q2 2023

Jul 24, 2023
BUY
$1.01 - $1.42 $29,637 - $41,668
29,344 Added 55.53%
82,185 $92,000
Q1 2023

Jun 03, 2024
BUY
$0.75 - $1.98 $39,630 - $104,625
52,841 New
52,841 $67,000
Q1 2023

Apr 12, 2023
BUY
$0.75 - $1.98 $39,630 - $104,625
52,841 New
52,841 $67,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email